UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)

International journal of gynecological cancer, 2024-03, Vol.34 (6), p.942-945

2024

Volltextzugriff (PDF)

Response of folliculotropic mycosis fungoides to capecitabine

Journal der Deutschen Dermatologischen Gesellschaft, 2023-07, Vol.21 (7), p.792-794

2023

Volltextzugriff (PDF)

Ansprechen follikulotroper Mycosis fungoides auf Capecitabin

Journal der Deutschen Dermatologischen Gesellschaft, 2023-07, Vol.21 (7), p.792-794

2023

Volltextzugriff (PDF)

Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?

Cancer, 2019-12, Vol.125 (S24), p.4616-4622

2019

Volltextzugriff (PDF)

A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial

International journal of gynecological cancer, 2021-04, Vol.31 (4), p.617-622

2021

Volltextzugriff (PDF)

Ansprechen follikulotroper Mycosis fungoides auf Capecitabin

Journal der Deutschen Dermatologischen Gesellschaft, 2023-07, Vol.21 (7), p.792-794

2023

Volltextzugriff (PDF)

Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017-05, Vol.20 (3), p.465-474

2017

Volltextzugriff (PDF)

Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It

Clinical Medicine Insights. Oncology, 2016-01, Vol.2016 (Suppl. 1), p.21-30

2016

Volltextzugriff (PDF)

The BRCA Gene in Epithelial Ovarian Cancer

Cancers, 2022-02, Vol.14 (5), p.1235

2022

Volltextzugriff (PDF)

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine

Nature communications, 2024-08, Vol.15 (1), p.6870-9, Article 6870

2024

Volltextzugriff (PDF)

First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions

Drugs (New York, N.Y.), 2014-06, Vol.74 (8), p.879-889

2014

Volltextzugriff (PDF)

235 Succor cone: is it cervical conization a protective maneuver

International journal of gynecological cancer, 2020-12, Vol.30 (Suppl 4), p.A7-A8

2020

Volltextzugriff (PDF)

Management challenges in low-grade serous ovarian cancer with a BRCA mutation

International journal of gynecological cancer, 2024-04, Vol.34 (4), p.631-636

2024

Volltextzugriff (PDF)

2022-RA-1309-ESGO Analysis of the prognostic value of systemic inflammation markers obtained from the complete blood count in patients treated for advanced ovarian carcinoma at the CUN in the period 2000–2015

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A321-A321

2022

Volltextzugriff (PDF)

Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study

Cancer chemotherapy and pharmacology, 2019-10, Vol.84 (4), p.781-789

2019

Volltextzugriff (PDF)

SENECA study: staging endometrial cancer based on molecular classification

International journal of gynecological cancer, 2024-08

2024

Volltextzugriff (PDF)

2022-RA-466-ESGO Long-term responders (LTR) to rucaparib in recurrent ovarian cancer: a sub-group analysis from the rucaparib access (RAP) program in Spain by GEICO

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A238-A238

2022

Volltextzugriff (PDF)

1338 Unveiling the clinical impact of tumor-based next-generation sequencing in ovarian cancer: insights from real-world data

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A582-A583

2024

Volltextzugriff (PDF)

Clinical insights from the rucaparib access program in Spain: A sub-analysis of long-term responders by GEICO

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17562-e17562

2022

Volltextzugriff (PDF)

Clinical experience with rucaparib after prior PARPi treatment: A subanalysis from the rucaparib access program in Spain by GEICO

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17598-e17598

2022

Volltextzugriff (PDF)

On the Effect of Triplet or Doublet Chemotherapy in Advanced Gastric Cancer: Results From a National Cancer Registry

Journal of the National Comprehensive Cancer Network, 2016-11, Vol.14 (11), p.1379

2016

Volltextzugriff (PDF)

572 Seneca sentinel: risk factors for unsuccessful bilateral sentinel lymph node mapping in endometrial cancer

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A22-A23

2024

Volltextzugriff (PDF)

930 Exploring the influence of volume center on surgical outcomes in the management of early-stage endometrial cancer: a subanalysis of the SENECA study

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A29-A30

2024

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(42)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(16)
Ovarian Cancer
(12)
Humans
(11)
Oncology
(11)
Patients
(10)
Female
(9)
Male
(7)
Cancer Therapies
(6)
Chemotherapy
(6)
Tumors
(6)
Aged
(5)
Medicine
(5)
Pharmacology & Pharmacy
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Biological And Medical Sciences
(4)
Medical Prognosis
(4)
Medical Sciences
(4)
Medicine & Public Health
(4)
Middle Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)

Response of folliculotropic mycosis fungoides to capecitabine

Ansprechen follikulotroper Mycosis fungoides auf Capecitabin

Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?

Ansprechen follikulotroper Mycosis fungoides auf Capecitabin

Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer

Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It

The BRCA Gene in Epithelial Ovarian Cancer

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine

First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions

235 Succor cone: is it cervical conization a protective maneuver

Management challenges in low-grade serous ovarian cancer with a BRCA mutation

2022-RA-1309-ESGO Analysis of the prognostic value of systemic inflammation markers obtained from the complete blood count in patients treated for advanced ovarian carcinoma at the CUN in the period 2000–2015

Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study

Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network

SENECA study: staging endometrial cancer based on molecular classification

2022-RA-466-ESGO Long-term responders (LTR) to rucaparib in recurrent ovarian cancer: a sub-group analysis from the rucaparib access (RAP) program in Spain by GEICO

1338 Unveiling the clinical impact of tumor-based next-generation sequencing in ovarian cancer: insights from real-world data

Clinical insights from the rucaparib access program in Spain: A sub-analysis of long-term responders by GEICO

Clinical experience with rucaparib after prior PARPi treatment: A subanalysis from the rucaparib access program in Spain by GEICO

On the Effect of Triplet or Doublet Chemotherapy in Advanced Gastric Cancer: Results From a National Cancer Registry

572 Seneca sentinel: risk factors for unsuccessful bilateral sentinel lymph node mapping in endometrial cancer

930 Exploring the influence of volume center on surgical outcomes in the management of early-stage endometrial cancer: a subanalysis of the SENECA study

Suchergebnisse filtern